
Study shows that early use of tirzepatide for diabetes yields cardiac benefits
Early use of tirzepatide appears to improve blood sugar, weight, and several heart-related risk markers in people with recently diagnosed type 2 diabetes. In interim findings from the SURPASS-EARLY trial conducted by Eli Lillyshowed that patients





